Integrin Receptor Antagonist class drugs
1 result
Entyvio (vedolizumab)
(vedolizumab)Takeda Pharmaceuticals America, Inc.
Usage: ENTYVIO is indicated for adults with moderately to severely active ulcerative colitis (UC) and moderately to severely active Crohn's disease (CD).